Hepatitis C vaccine (Heber Biotech)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHepatitis C vaccine (Heber Biotech)
Drug Alias Name丙型肝炎疫苗 - Heber BiotechCIGB 230 vaccineTerap-CCIGB-230
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCenter For Genetic Engineering And Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCenter For Genetic Engineering And Biotechnology
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A